Author:
Belardinelli Juan M.,Li Wei,Avanzi Charlotte,Angala Shiva K.,Lian Elena,Wiersma Crystal J.,Palčeková Zuzana,Martin Kevin H.,Angala Bhanupriya,de Moura Vinicius C. N.,Kerns Callan,Jones Victoria,Gonzalez-Juarrero Mercedes,Davidson Rebecca M.,Nick Jerry A.,Borlee Bradley R.,Jackson Mary
Abstract
Characterizing Mycobacterium abscessus complex (MABSC) biofilms under host-relevant conditions is essential to the design of informed therapeutic strategies targeted to this persistent, drug-tolerant, population of extracellular bacilli. Using synthetic cystic fibrosis medium (SCFM) which we previously reported to closely mimic the conditions encountered by MABSC in actual cystic fibrosis (CF) sputum and a new model of biofilm formation, we show that MABSC biofilms formed under these conditions are substantially different from previously reported biofilms grown in standard laboratory media in terms of their composition, gene expression profile and stress response. Extracellular DNA (eDNA), mannose-and glucose-containing glycans and phospholipids, rather than proteins and mycolic acids, were revealed as key extracellular matrix (ECM) constituents holding clusters of bacilli together. None of the environmental cues previously reported to impact biofilm development had any significant effect on SCFM-grown biofilms, most likely reflecting the fact that SCFM is a nutrient-rich environment in which MABSC finds a variety of ways of coping with stresses. Finally, molecular determinants were identified that may represent attractive new targets for the development of adjunct therapeutics targeting MABSC biofilms in persons with CF.
Funder
Cystic Fibrosis Trust
Cystic Fibrosis Foundation
National Institutes of Health
Vertex Pharmaceuticals
Horizon 2020 Framework Programme
Subject
Microbiology (medical),Microbiology
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献